by AstraZeneca
This resource provides information on IMFINZI and how it is used for treatment of several cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), removable stomach (gastric) or gastroesophageal junction cancer, unresectable hepatocellular carcinoma (liver cancer), bile duct cancer and gallbladder cancer, muscle-invasive bladder cancer (MIBC), and advanced or recurrent dMMR endometrial cancer. It helps with treatment resources, options for assistance, and financial support through patient savings program.
